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OBJECTIVE: To study tremor in patients with X-linked recessive spinobulbar muscular atrophy or Kennedy’s disease.
METHODS: Ten patients (from 7 families) with a genetic diagnosis of Kennedy’s disease were screened for the
presence of tremor using a standardized clinical protocol and followed up at a neurology outpatient clinic. All index
patients were genotyped and showed an expanded allele in the androgen receptor gene.
RESULTS: Mean patient age was 37.6 years and mean number of CAG repeats 47 (44-53). Tremor was present in 8
(80%) patients and was predominantly postural hand tremor. Alcohol responsiveness was detected in 7 (88%)
patients with tremor, who all responded well to treatment with a b-blocker (propranolol).
CONCLUSION: Tremor is a common feature in patients with Kennedy’s disease and has characteristics similar to
those of essential tremor.
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INTRODUCTION
X-linked recessive spinal and bulbar atrophy, or
Kennedy’s disease (KD), is a rare lower motor neuron
disease associated with a mutation in exon 1 of the
androgen receptor gene on the long arm of chromosome X
(Xq 11-12).
1,2 The condition results from a CAG trinucleo-
tide expansion at the 59 end of this gene of between 40 and
62 repeats (normal values between 11 and 33). The direct
relationship between the size of the expansion, lower age of
onset and predominance of motor symptoms has been well
documented.
3,4 KD is usually classified among progressive
spinal muscular atrophies and is clinically characterized by
onset in the third decade of life with fasciculations followed
by slowly progressive proximal muscle weakness and
wasting of the proximal and, less often, distal musculature
at approximately 40 years of age. Other features include
cramps on exertion, areflexia, bulbar signs, dysphagia, and,
in some patients, signs of androgen insensitivity, such as
gynecomastia, testicular atrophy and oligospermia. The
clinical syndrome occurs in the absence of pyramidal,
sensory, and cerebellar signs, suggesting a more prominent
lower motor neuron involvement. The disorder is usually
compatible with a long life. Female homozygotes are
generally asymptomatic but some reported cases have
included much milder clinical manifestations such as
occasional muscle cramps and perioral fasciculations, and
hand tremor.
Tremor is rarely described in most motor neuron diseases,
but may not be uncommon if a specific search is made. For
instance, in spinal muscle atrophy types 2 and 3, postural
tremor, sometimes linked to fasciculations, is occasionally
found on examination.
5 Additionally, a study assessing
extra pyramidal features of amyotrophic lateral sclerosis
found a frequency of tremor in 40% of patients, especially in
those with a family history.
5 Tremor is also a less common
sign in KD.
1-4,6-9 Currently, an extensive search is being
made for an appropriate biomarker and an effective
treatment for KD.
10,11
Here we report 10 confirmed cases of KD, in which the
presence of tremor is assessed and the clinical characteristics
of the disease are demonstrated using a standard assess-
ment protocol.
METHODS
We assessed 10 male patients (from 7 different families)
with a genetically established diagnosis of KD who were
followed up in the neuromuscular disease and movement
disorders outpatient units at the Hospital de Clı ´nicas,
Federal University of Parana ´, and the private practices of
two of the authors (HAGT and LCW). All patients signed an
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955informed consent form. Molecular genetic testing was
carried out at the Genetika laboratory to determine the
number of CAG repeats in exon 1 of the androgen receptor
gene on the long arm of chromosome X. The normal cut-off
point for repeats considered here was , 34 CAG.
Clinical assessment included demographic data such as
current age, age of onset, defined retrospectively by
determining the age at which the first symptom or sign
attributable to KD was detected, and the presence of hand
(predominantly resting, postural or intention), leg and head
tremor (according to Movement Disorder Society criteria).
Tremor response to alcohol and b-blockers was also
assessed (propranolol in doses of 80–160 mg/day).
RESULTS
The mean patient age at onset was 37.6 years, mean
number of CAG repeats 47 (41-53) and tremor (predomi-
nantly postural hand tremor) was found in 8 (80%) of the
patients. Intention tremor of the hands together with
postural tremor (also of the hands) was found in 4 patients;
of these 4, one also had tremor of the lower limbs. One
patient had postural tremor of the hands and head tremor.
All patients with tremor were exposed to alcohol with a
significant responsiveness detected in 7 (88%) patients who
all responded to b-blockers (propranolol up to 160 mg/
day). All patients had limb weakness, predominantly
proximal, associated with bulbar symptoms. Fasciculations
were found predominantly in the tongue, oral and cervical
muscles. Gynecomastia was found in 8 patients. Table 1
shows the clinical features of KD and molecular genetic
testing results in 10 patients.
DISCUSSION
In the original article by Kennedy et al.
1 published in
1968, in which 11 patients from two different families were
analyzed, fine tremor of the hands was observed in 4
patients (36.4%) and the authors emphasized the presence of
proximal muscle weakness of spinal and bulbar origin with
generalized fasciculations, especially in the region of the
chin and lips, and the absence of pyramidal signs and
sensory or cerebellar involvement.
Since then, diagnosis of KD has been associated with the
presence of muscle weakness and atrophy in the facial and
bulbar regions (with dysarthria and dysphagia) and
(proximal) limbs, together with cramps, fasciculations of
the tongue, lips and perioral region and other associated
characteristics such as gynecomastia, oligospermia and
azoospermia.
2-7,11,12
It fell to Atsuta et al.
4 in Japan to assess a large group of
223 patients with genetically established KD. The authors
defined the natural history of the disease and concluded
that action tremor of the hands was the earliest sign
reported by patients, with a mean age of onset of 33 years,
followed by muscle weakness (age of onset 44 years) and
death at 65 years. Therefore, these findings show that
tremor can precede weakness by several years (average 11
years). As other forms of postural tremor are more common
(e.g., essential tremor), its presence is like an ‘‘unskilled
sentinel’’ sign for KD, distracting clinicians from the final
diagnosis. Rhodes et al.,
6 assessing the clinical character-
istics of 57 patients with KD, found tremor in 23% of their
cases.
Phenomenologically, tremors are classically classified
according to their predominance related to posture of the
affected limbs. This criterion divides tremors into rest
predominant and action predominant. Rest tremor is
considered a synonym of parkinsonian tremor as it is a
cardinal feature of parkinsonism seen in Parkinson’s disease
and drug-induced parkinsonism (caused by dopamine
receptor antagonists, certain calcium channel blockers,
etc). Action tremor is divided into postural and kinetic
tremor. Although there is a significant overlap between
these two forms of action tremor, a more prominent
postural component is usually related to essential tremor,
degenerative diseases (Wilson’s disease, fragile X permuta-
tion tremor ataxia syndrome, etc) or is drug induced
(adrenergic drugs, valproate, lithium, etc). Kinetic tremor,
however, is typically related to dysfunction of the cerebel-
lum and its main afferent and efferent pathways, as found
in degenerative disorders (spinocerebellar ataxias,
Friedreich’s ataxia, etc) and structural lesions (vascular,
multiple sclerosis, trauma, tumors, etc).
14
In our Brazilian series of patients who had had KD for an
average of 9.3 years, tremor was found in 8 of the 10 patients
(80%). An interesting finding is that the tremor observed
had clinical characteristics similar to those of essential
tremor: it was predominantly of the hands, both postural
and intentional and improved with alcohol and the use of a
b-blocker. Leg and head tremor were found less frequently
in this Brazilian series, coinciding with findings in patients
with essential tremor. In light of the high prevalence of
essential tremor (one of the commonest movement dis-
orders) in the population in general, it is essential that a
more detailed assessment of these patients is carried out to
search for other signs and symptoms potentially related to
KD.
15 Also, the finding of some degree of responsiveness to
propranolol indicates that the tremor found in these patients
is, in part, related to central mechanisms.
In 2009 Hanajima et al.
16 published a memorable study in
which they carried out a neurophysiological assessment of
the presence of postural tremor in eight patients with a
Table 1 – Clinical features of Kennedy’s disease (tremor)
and molecular genetic testing in 10 patients (from 7
families).
Clinical features Patient
123456789 1 0
Family 1 22233456 7
Age 44 21 50 41 55 50 62 50 51 45
Age at onset* 40 19 40 35 49 44 43 39 37 30
Mean number of
CAG repeats
47 45 53 41 46 53 44 47 47 47
Hand postural
tremor
++--+++++ +
Hand intention
tremor
----+++- + -
Head tremor + -------- -
Leg tremor - - - - + ---- -
Alcohol
responsiveness
++NT NT ++++- +
b-Blocker
treatment
++--++++- +
*Age at onset was defined retrospectively by determining the age at
which the first symptom or sign attributable to Kennedy’s disease was
detected.
NT = not tested.
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tremor with a frequency of 6–9 Hz in 7 patients, a prevalence
similar to that of essential tremor. However, they concluded
that the tremor should be classified as reflex tremors in 5
patients and mechanical tremors in 3. Their findings also
suggest that the tremor found in KD must have a peripheral
origin, unlike essential tremor, which has a central origin.
Another interesting aspect of KD was studied by Suzuki et
al.
3 in 2008, who assessed 106 patients with a genetically
confirmed diagnosis of the disease. The authors defined
different phenotypes for the disease, including motor
(classic) and sensory phenotypes (with disturbance of deep
sensation, particularly vibratory sensation). They found a
correlation between the size of the CAG repeat expansion
and the electrophysiological findings: in general, for larger
CAG repeat expansions, the motor phenotype predominated,
and for smaller ones, the sensory phenotype.
CONCLUSION
Tremor is a common feature in patients with KD, and the
characteristics of the tremor found in this Brazilian series of
patients are similar to those of essential tremor.
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